Actinium Pharmaceuticals (ATNM) Common Equity (2010 - 2026)
Actinium Pharmaceuticals (ATNM) reported Common Equity of $30.3 million for Q2 2026, up 59.4% from $19.01 million a year earlier.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Actinium Pharmaceuticals posted Common Equity of $7.83 million, down 76.1% from FY2024.
- Common Equity has declined for four consecutive years, with a five-year compound annual growth rate of -33.7% (FY2020 to FY2025).
- By year, Common Equity came in at $32.76 million in FY2024 (-10.0%), $36.38 million in FY2023 (-45.3%), $66.48 million in FY2022 (-9.6%) and $73.55 million in FY2021 (+19.9%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity since Q4 2024.
- Year over year, Common Equity gained in 1 of the last eight quarters, with an average decline of 36.5%.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 76.7%); the low point was Q1 2026 (a decline of 91.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.3 million (Q1 2026), $7.83 million (Q4 2025) and $13.78 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Actinium Pharmaceuticals | 37.10 Mn | 37.10 Mn | - | 30.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.30 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 7.83 Mn |
| Sep 30, 2025 | 13.78 Mn |
| Jun 30, 2025 | 19.01 Mn |
| Mar 31, 2025 | 25.69 Mn |
| Dec 31, 2024 | 32.76 Mn |
| Sep 30, 2024 | 38.21 Mn |
| Jun 30, 2024 | 43.84 Mn |
| Mar 31, 2024 | 43.86 Mn |
| Dec 31, 2023 | 36.38 Mn |
| Sep 30, 2023 | 43.58 Mn |
| Jun 30, 2023 | 53.08 Mn |
| Mar 31, 2023 | 57.21 Mn |
| Dec 31, 2022 | 66.48 Mn |
| Sep 30, 2022 | 71.26 Mn |
| Jun 30, 2022 | 78.18 Mn |
| Mar 31, 2022 | 68.84 Mn |
| Dec 31, 2021 | 73.55 Mn |
| Sep 30, 2021 | 80.29 Mn |
API Access
Actinium Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();